Aggregation of multiple sclerosis genetic risk variants in multiple and single case families

Annals of Neurology

Volumn 69, Issue 1, 2011, Pages 65-74

  Gourraud, Pierre Antoine ^a   McElroy, Joseph P ^a   Caillier, Stacy J ^a   Johnson, Britt A ^a   Santaniello, Adam ^a   Hauser, Stephen L ^a   Oksenberg, Jorge R ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HLA DR ANTIGEN;

ADULT; ALLELE; ARTICLE; CONTROLLED STUDY; FAMILY; FEMALE; GENDER; GENETIC DATABASE; GENETIC RISK; GENETIC SUSCEPTIBILITY; GENETIC VARIABILITY; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTIPLE SCLEROSIS; PREDICTION; PRIORITY JOURNAL; SIBLING; SINGLE NUCLEOTIDE POLYMORPHISM;

ADULT; ALLELES; CASE-CONTROL STUDIES; CHROMOSOME MAPPING; FAMILY; FEMALE; GENETIC HETEROGENEITY; GENETIC PREDISPOSITION TO DISEASE; GENETIC VARIATION; GENOME-WIDE ASSOCIATION STUDY; GENOTYPE; HLA-DR ANTIGENS; HUMANS; MALE; MULTIPLE SCLEROSIS; PEDIGREE; POLYMORPHISM, GENETIC; POLYMORPHISM, SINGLE NUCLEOTIDE; RISK FACTORS;

EID: 79551484517     PISSN: 03645134     EISSN: 15318249     Source Type: Journal    
DOI: 10.1002/ana.22323     Document Type: Article

References (30)

1. De Jager PL, Jia X, Wang J, et al. Meta-analysis of genome scans and replication identify CD6, IRF8 and TNFRSF1A as new multiple sclerosis susceptibility loci. Nat Genet 2009; 41: 776-782.
2. Oksenberg JR, Baranzini SE, Sawcer S, Hauser SL., The genetics of multiple sclerosis: SNPs to pathways to pathogenesis. Nat Rev Genet 2008; 9: 516-526.
3. ANZGENE Consortium. Genome-wide association study identifies new multiple sclerosis susceptibility loci on chromosomes 12 and 20. Nat Genet 2009; 41: 824-828.
4. IMSGC Consortium. Comprehensive follow-up of the first genome-wide association study of multiple sclerosis identifies KIF21B and TMEM39A as susceptibility loci. Hum Mol Genet 2010; 19: 953-962.
5. Baranzini SE, Wang J, Gibson RA, et al. Genome-wide association analysis of susceptibility and clinical phenotype in multiple sclerosis. Hum Mol Genet 2009; 18: 767-778.
6. Burton PR, Clayton DG, Cardon LR, et al. Association scan of 14,500 nonsynonymous SNPs in four diseases identifies autoimmunity variants. Nat Genet 2007; 39: 1329-1337.
7. Comabella M, Craig DW, Camina-Tato M, et al. Identification of a novel risk locus for multiple sclerosis at 13q31.3 by a pooled genome-wide scan of 500,000 single nucleotide polymorphisms. PLoS One 2008; 3: e3490.
8. Jakkula E, Leppa V, Sulonen AM, et al. Genome-wide association study in a high-risk isolate for multiple sclerosis reveals associated variants in STAT3 gene. Am J Hum Genet 2010; 86: 285-291.
9. Sawcer S, Ban M, Wason J, Dudbridge F., What role for genetics in the prediction of multiple sclerosis? Ann Neurol 2010; 67: 3-10.
10. Sadovnick AD, Baird PA, Ward RH., Multiple sclerosis: updated risks for relatives. Am J Med Genet 1988; 29: 533-541.
11. Smith-Bouvier DL, Divekar AA, Sasidhar M, et al. A role for sex chromosome complement in the female bias in autoimmune disease. J Exp Med 2008; 205: 1099-1108.
12. Bentzen J, Flachs EM, Stenager E, et al. Prevalence of multiple sclerosis in Denmark 1950-2005. Mult Scler 2010; 16: 520-525.
13. Orton SM, Herrera BM, Yee IM, et al. Sex ratio of multiple sclerosis in Canada: a longitudinal study. Lancet Neurol 2006; 5: 932-936.
14. Hafler JP, Maier LM, Cooper JD, et al. CD226 Gly307Ser association with multiple autoimmune diseases. Genes Immun 2009; 10: 5-10.
15. Johnson BA, Wang J, Taylor EM, et al. Multiple sclerosis susceptibility alleles in African Americans. Genes Immun 2010; 11: 343-350.
16. Barcellos LF, Oksenberg JR, Green AJ, et al. Genetic basis for clinical expression in multiple sclerosis. Brain 2002; 125: 150-158.
17. Goodkin DE, Doolittle TH, Hauser SS, et al. Diagnostic criteria for multiple sclerosis research involving multiply affected families. Arch Neurol 1991; 48: 805-807.
18. De Jager PL, Chibnik LB, Cui J, et al. Integration of genetic risk factors into a clinical algorithm for multiple sclerosis susceptibility: a weighted genetic risk score. Lancet Neurol 2009; 8: 1111-1119.
19. D'Netto MJ, Ward H, Morrison KM, et al. Risk alleles for multiple sclerosis in multiplex families. Neurology 2009; 72: 1984-1988.
20. Kantarci OH, Barcellos LF, Atkinson EJ, et al. Men transmit MS more often to their children vs women: the Carter effect. Neurology 2006; 67: 305-310.
21. Ramagopalan SV, Giovannoni G., Can we predict multiple sclerosis ? Lancet Neurol 2009; 8: 1077-1079.
22. Dickson SP, Wang K, Krantz I, et al. Rare variants create synthetic genome-wide associations. PLoS Biol 2010; 8: e1000294.
23. Barcellos LF, Sawcer S, Ramsay PP, et al. Heterogeneity at the HLA-DRB1 locus and risk for multiple sclerosis. Hum Mol Genet 2006; 15: 2813-2824.
24. Bergamaschi L, Leone MA, Fasano ME, et al. HLA-class I markers and multiple sclerosis susceptibility in the Italian population. Genes Immun 2010; 11: 173-180.
25. Ramagopalan SV, Knight JC, Ebers GC., Multiple sclerosis and the major histocompatibility complex. Curr Opin Neurol 2009; 22: 219-225.
26. Chao MJ, Ramagopalan SV, Herrera BM, et al. Epigenetics in multiple sclerosis susceptibility: difference in transgenerational risk localizes to the major histocompatibility complex. Hum Mol Genet 2009; 18: 261-266.
27. Kremenchutzky M., Primary progressive MS. Int MS J 2003; 10: 89-95.
28. Confavreux C, Vukusic S., Natural history of multiple sclerosis: a unifying concept. Brain 2006; 129: 606-616. (Pubitemid 43278223)
29. Ascherio A, Munger KL., Environmental risk factors for multiple sclerosis. Part II: Noninfectious factors. Ann Neurol 2007; 61: 504-513. (Pubitemid 47068132)
30. Ascherio A, Munger KL., Environmental risk factors for multiple sclerosis. Part I: The role of infection. Ann Neurol 2007; 61: 288-299. (Pubitemid 46676728)